Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-11-30

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hypertension Type II DM DM related complication JNC7 2007 ESH-ESC guidelines survey

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Type II Diabetes Mellitus patients with Complication and Hypertension

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* After diagnosed type II DM, patients received treatment for a least 3 years
* Type II DM patients with hypertension and its complication.
* Visited out-patients to care center after 1 Jan. 2008

Exclusion Criteria

* Secondary hypertension patients
* Patients not receiving hypertension medication
* Patients stopping BP medication, by physician's order
* Patients currently enrolled in other clinical studies

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joonwoo Bahn

Role: STUDY_DIRECTOR

Astrazenca Korea

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CKR-DUM-2008/3

Identifier Type: -

Identifier Source: org_study_id

Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension

Study Results

Basic Information

Brief Summary

Detailed Description

Conditions

Keywords

Study Design

Study Groups

1

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sponsors

AstraZeneca

Principal Investigators

Joonwoo Bahn

Locations

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Countries

Other Identifiers

NIS-CKR-DUM-2008/3